Dear Reader,
Welcome to the Q2 2020 version of our quarterly 'Chemicals and Life Sciences M&A Director' newsletter!

Firstly, thank you to all those that responded regarding the previous Q1 edition - it is good to hear the information we are assembling below is of use. Please continue to feedback with your comments and suggestions, or article submissions. We want to make this interactive and as useful as possible.
Secondly, we've noticed a wave of notifications informing us that several postponed exhibitions and conferences have now been further pushed back into next year. So we know we're not alone as we say we've decided to do the same with our sister-event, the 'Better Inorganic Growth' conference. This is now being planned for 2021 - please watch this space!
Lastly, although still largely stuck in our home offices, we've noticed a decided up-tick in enquiries regarding strategic buy/sell options. We sense a wave of momentum coming out of this unique period - and we are expecting to be working on several strategic "re-pivots" in the coming months as businesses adapt to the shifting marketplace. If you'd like to discuss anything similar with one of our team, please let us know.

Wishing you all health and happiness during these continued turbulent times.
Matt Dixon, CCD Partners
Target | Buyer | Seller | Target Sector | Synopsis / Title | Link to Source |
---|---|---|---|---|---|
BRB | Petronas Chemicals | Private | Specialty Chemicals and Advanced Materials | Petronas Chemicals has completed the acquisition BRB Silicones | Source |
CosBond | Azelis | Private | Chemical Distribution and Supply | Azelis acquires Chinese personal care specialty chemicals distributor | Source |
Omnova Solutions | Synthomer | Private | Specialty Chemicals and Advanced Materials | Synthomer completes its US acquisition of Omnova | Source |
Syntor Fine Chemicals | Aceto | Private | Fine and Life Sciences Contract Services | US-based specialty materials supplier Aceto has acquired UK-based Syntor Fine Chemicals | Source |
Pharma business | IMCD | Develing International Trade | Chemical Distribution and Supply | IMCD acquires pharmaceutical business in China of Develing | Source |
Biopharma facility | AGC Biologics | AstraZeneca | Fine and Life Sciences Contract Services | AGC Biologics has acquired a commercial biopharmaceutical facility in Colorado, US from AstraZeneca | Source |
Name | From | To | Role | Link to Source |
---|---|---|---|---|
Helen Stimson | Delaware BioScience Association | Adesis | COO | Source |
Guillaume Clément | Flint Group | Blanchon Group | CEO | Source |
Pierre-Alain Ruffieux | Roche | Lonza | CEO | Source |
Monish Patolawala | GE Healthcare | 3M | SVP CFO | Source |
Mike Gaffney | Callery | VanDeMark Chemical | CFO | Source |
Lance Hyde | EQT Corporation | Koppers | Director of Global Inclusion and Diversity | Source |
Thank you for contacting us.
We will get back to you as soon as possible.
Oops, there was an error sending your message.
Please try again later.